|
|
Evaluating ADGRB3 as a tumor suppressor epigenetically silenced in WNT medulloblastoma |
| 3R01CA235162-04S1 |
|
NCI |
2022 |
|
|
Investigating Microenvironmental Interactions in Leptomeningeal Metastasis |
| 5R01CA245499-03 |
|
NCI |
2022 |
|
|
Endovascular ChemoFilter to Reduce Doxorubicin Toxicity during Intra-Arterial Chemotherapy |
| 1 R42 CA265316-01 |
|
NCI |
2021 |
|
|
INTERFERON SIGNALING AND THE DIFFERENTIAL MALIGNANCY SPECTRUM OF DOWN SYNDROME |
| 3P30CA046934-31S6 |
SCHULICK, RICHARD D |
NCI |
2019 |
|
|
MECHANISMS OF LEUKEMOGENESIS IN DOWN SYNDROME |
| 5R01CA101774-17 |
CRISPINO, JOHN D |
NCI |
2019 |
|
|
DEEP PHENOTYPING AND PAN-OMICS OF ACUTE LYMPHOBLASTIC LEUKEMIA IN DOWN SYNDROME |
| 3P30CA125123-12S4 |
OSBORNE, C KENT |
NCI |
2018 |
|
|
MECHANISMS OF LEUKEMOGENESIS IN DOWN SYNDROME |
| 3R01CA101774-16S1 |
CRISPINO, JOHN D |
NCI |
2018 |
|
|
MECHANISMS OF GENE EXPRESSION CONTROL IN THE P53 NETWORK |
| 3R01CA117907-12A1S1 |
ESPINOSA, JOAQUIN M. |
NCI |
2018 |
|
|
TARGETING CHROMATIN MODIFICATIONS IN LEUKEMIA WITH TRISOMY 21 |
| 5K08CA181340-05 |
LANE, ANDREW A |
NCI |
2018 |
|
|
MECHANISMS OF LEUKEMOGENESIS IN DOWN SYNDROME |
| 5R01CA101774-16 |
CRISPINO, JOHN D |
NCI |
2018 |
